43.25
전일 마감가:
$44.46
열려 있는:
$44.93
하루 거래량:
1.16M
Relative Volume:
1.23
시가총액:
$3.30B
수익:
-
순이익/손실:
$-64.16M
주가수익비율:
-34.05
EPS:
-1.2702
순현금흐름:
$-69.06M
1주 성능:
+8.61%
1개월 성능:
+28.61%
6개월 성능:
+145.32%
1년 성능:
+25.44%
Cg Oncology Inc Stock (CGON) Company Profile
명칭
Cg Oncology Inc
전화
(949) 419-6203
주소
400 SPECTRUM CENTER DRIVE, IRVINE
CGON을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CGON
Cg Oncology Inc
|
43.25 | 3.39B | 0 | -64.16M | -69.06M | -1.2702 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-10-08 | 개시 | Guggenheim | Buy |
2025-08-19 | 개시 | Piper Sandler | Overweight |
2025-07-10 | 재개 | Goldman | Buy |
2025-05-02 | 개시 | JP Morgan | Overweight |
2025-04-16 | 개시 | Scotiabank | Sector Perform |
2025-01-07 | 개시 | TD Cowen | Buy |
2024-10-24 | 개시 | UBS | Buy |
2024-09-23 | 개시 | RBC Capital Mkts | Outperform |
2024-08-28 | 개시 | ROTH MKM | Buy |
2024-06-28 | 개시 | BofA Securities | Buy |
2024-02-20 | 개시 | Cantor Fitzgerald | Overweight |
2024-02-20 | 개시 | Goldman | Neutral |
2024-02-20 | 개시 | Morgan Stanley | Overweight |
2024-02-14 | 개시 | H.C. Wainwright | Buy |
모두보기
Cg Oncology Inc 주식(CGON)의 최신 뉴스
How to recover losses in CG Oncology Inc. stockJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
James Mulay Sells 5,903 Shares of CG Oncology (NASDAQ:CGON) Stock - MarketBeat
Midday Stock Roundup: EnVVeno down 15% - Orange County Business Journal
CG Oncology (NASDAQ:CGON) Reaches New 1-Year HighHere's What Happened - MarketBeat
CG Oncology (NASDAQ:CGON) Now Covered by Analysts at Guggenheim - MarketBeat
Is this a good reentry point in CG Oncology Inc.2025 Institutional Moves & Fast Gaining Stock Strategy Reports - newser.com
Candlestick signals on CG Oncology Inc. stock todayJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
CG Oncology (NASDAQ:CGON) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
CG Oncology (CGON): Assessing Valuation Following Analyst Coverage and Positive Phase 3 Trial Results - Yahoo Finance
CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic? (NASDAQ:CGON) - Seeking Alpha
CG Oncology’s Surging Prospects: Buy or Hold? - StocksToTrade
When is the best time to exit CG Oncology Inc.Stop Loss & Expert Verified Movement Alerts - newser.com
CG Oncology Inc. recovery potential after sell offJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Price momentum metrics for CG Oncology Inc. explainedJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Ranking CG Oncology Inc. among high performing stocks via toolsLong Setup & Accurate Entry/Exit Alerts - newser.com
Why Cg Oncology Stock Rocketed 7% Higher Today - The Globe and Mail
Why Cg Oncology Stock Rocketed 7% Higher Today - The Motley Fool
CG Oncology (NASDAQ:CGON) Trading 7.1% HigherHere's What Happened - MarketBeat
CG Oncology stock initiated Buy at Guggenheim (CGON:NASDAQ) - Seeking Alpha
Guggenheim Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage on CG Oncology With Buy Rating, $90 Price Target - MarketScreener
Applying Elliott Wave Theory to CG Oncology Inc.Portfolio Profit Report & Verified Swing Trading Watchlists - newser.com
What’s next for CG Oncology Inc. stock priceProduct Launch & High Return Trade Opportunity Guides - newser.com
How CG Oncology Inc. stock reacts to bond yieldsQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
How to monitor CG Oncology Inc. with trend dashboardsJuly 2025 Update & Safe Entry Point Alerts - newser.com
Will a bounce in CG Oncology Inc. offer an exitJuly 2025 Institutional & Long-Term Investment Growth Plans - newser.com
How analysts rate CG Oncology Inc. stock today2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
CG Oncology (NASDAQ:CGON) Upgraded to Hold at Wall Street Zen - Defense World
CG Oncology (NASDAQ:CGON) Raised to "Hold" at Wall Street Zen - MarketBeat
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Best data tools to analyze CG Oncology Inc. stockQuarterly Trade Summary & Low Drawdown Trading Strategies - newser.com
Can you recover from losses in CG Oncology Inc.2025 Technical Overview & Fast Entry High Yield Stock Tips - newser.com
AMI Asset Management Corp Purchases New Stake in CG Oncology, Inc. $CGON - MarketBeat
CG Oncology (NASDAQ:CGON) Director Leonard Post Sells 5,000 Shares of Stock - MarketBeat
Cg Oncology stock hits 52-week high at 40.49 USD By Investing.com - Investing.com Nigeria
Cg Oncology stock hits 52-week high at 40.49 USD - Investing.com
CG Oncology (NASDAQ:CGON) Director James Mulay Sells 12,755 Shares - MarketBeat
Cg Oncology Inc (CGON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cg Oncology Inc 주식 (CGON) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Mulay James | Director |
Oct 09 '25 |
Sale |
43.99 |
5,903 |
259,673 |
0 |
자본화:
|
볼륨(24시간):